Tag Archive for: Healthcare Communications UK

Weekly Roundup: Curate your conference calendar

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s disease AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases, announced that it has received Fast Track designation and clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug […]

Weekly Roundup: Keeping score on the sector

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline Cambridge (UK) based Mission Therapeutics, a clinical-stage biotechnology company developing novel therapeutics that promote the removal of dysfunctional mitochondria to restore cellular health and function, announced the divestment of MTX652, […]

Weekly Roundup: Appointments and new perspectives

Hansa Biopharma appointed Adam Cutler as new Chief Financial Officer Hansa Biopharma AB announced the appointment of Adam Cutler as its new Chief Financial Officer (CFO) and member of the Executive Committee, effective June 22, 2026.  Adam succeeds Evan Ballantyne, who has served as CFO since 2024. Evan will continue in the role until June […]

Weekly Roundup: Biotech in bloom this June

The heatwave has been replaced by heavy showers, but June is looking bright for our clients, with huge congratulations to Ona Therapeutics for its $86.6M Series B financing and to DaltonTx  for the launch of its AI-enabled drug discovery platform. Dr. Hans Eriksson is joining FundaMental Pharma’s team as CMO and Renée Aguiar-Lucander participated in […]

Optimum celebrates the International Day of Women & Girls in Science 2026

To mark this year’s International Day of Women and Girls in Science, Optimum is celebrating the remarkable women across our network by asking them: ‘If you could collaborate with any scientist (past or present) who would it be, and why?’ Their answers were as inspiring as they were diverse, from trailblazing pioneers to modern innovators, […]

© Optimum Strategic Communications.